{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:34:20Z","timestamp":1791182060234,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"content-version":"vor","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.leukres.2014.07.010","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T09:15:01Z","timestamp":1406884501000},"page":"1245-1251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412"],"prefix":"10.1016","volume":"38","author":[{"given":"Paula","family":"de Melo Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o A.","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Scopim-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Visconte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tabarroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana S.S.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via F.C.","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Vassalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesun J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lorand-Metze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon V.","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-8068","authenticated-orcid":false,"given":"Sara T.","family":"Olalla Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.07.010_bib0005","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.07.010_bib0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","article-title":"Evaluation of the WHO criteria for the classification of patients with mastocytosis","volume":"24","author":"Sanchez-Munoz","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.07.010_bib0020","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.07.010_bib0030","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"key":"10.1016\/j.leukres.2014.07.010_bib0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood-2012-07-442400","article-title":"Mast cell leukemia","volume":"121","author":"Georgin-Lavialle","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.07.010_bib0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ajh.23459","article-title":"Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management","volume":"88","author":"Pardanani","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.1986.01660130084031","article-title":"Familial urticaria pigmentosa","volume":"122","author":"Fowler","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0050","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1001\/archinte.1990.00040031742025","article-title":"Familial urticaria pigmentosa","volume":"150","author":"Clark","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.leukres.2014.07.010_bib0055","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/archderm.1990.01670350092016","article-title":"The familial occurrence of bullous mastocytosis (diffuse cutaneous mastocytosis)","volume":"126","author":"Oku","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1991.tb14800.x","article-title":"Familial mastocytosis: a clinical, immunophenotypic, light and electron microscopic study","volume":"125","author":"Anstey","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1525-1470.2001.01939.x","article-title":"Familial cutaneous mastocytosis","volume":"18","author":"Chang","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","article-title":"Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis","volume":"129","author":"Hartmann","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.leukres.2014.07.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2011.05.009","article-title":"Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis","volume":"39","author":"Wasag","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/PAS.0b013e3182986b88","article-title":"Gastrointestinal Stromal tumors with KIT exon 9 mutations: update on genotype\u2013phenotype correlation and validation of a high-resolution melting assay for mutational testing","volume":"37","author":"Kunstlinger","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaci.2012.11.040","article-title":"Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis","volume":"131","author":"Zanotti","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0090","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood.V97.11.3559","article-title":"Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells","volume":"97","author":"Ning","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.07.010_bib0095","first-page":"3043","article-title":"The Steel\/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor","volume":"11","author":"Rottapel","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","article-title":"Early signaling pathways activated by c-Kit in hematopoietic cells","volume":"31","author":"Linnekin","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0105","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2014.07.010_bib0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2014.07.010_bib0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.07.010_bib0125","doi-asserted-by":"crossref","first-page":"e43090","DOI":"10.1371\/journal.pone.0043090","article-title":"Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis","volume":"7","author":"Traina","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.leukres.2014.07.010_bib0130","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.07.010_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(02)03845-0","article-title":"BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells","volume":"535","author":"Traina","year":"2003","journal-title":"FEBS Lett"},{"issue":"Suppl.","key":"10.1016\/j.leukres.2014.07.010_bib0140","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1016\/j.jaci.2004.01.683","article-title":"Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations","volume":"113","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0145","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu047","article-title":"Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal","author":"Valent","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.07.010_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.12.1090","article-title":"Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype","volume":"134","author":"Chan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12185-008-0166-4","article-title":"Advanced mast cell disease: an Italian Hematological Multicenter experience","volume":"88","author":"Pagano","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2014.07.010_bib0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","article-title":"Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies","volume":"66","author":"Schittenhelm","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2014.07.010_bib0170","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2014.07.010_bib0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.07.010_bib0180","doi-asserted-by":"crossref","first-page":"25572","DOI":"10.1074\/jbc.M002218200","article-title":"Stem cell factor\/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase\/p70 S6 kinase pathway in spermatogonia","volume":"275","author":"Feng","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2014.07.010_bib0185","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2004-12-4617","article-title":"Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412","volume":"106","author":"Growney","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.07.010_bib0190","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1535-7163.MCT-06-0641","article-title":"Resistance to c-KIT kinase inhibitors conferred by V654A mutation","volume":"6","author":"Roberts","year":"2007","journal-title":"Mol Cancer Ther"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261400232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261400232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:58:50Z","timestamp":1758934730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261400232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S014521261400232X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.07.010","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}